Go to main content
logo unither pharmaceuticals site internet
  • 简体中文 | ZH-HANS
  • Français | FR
  • Português | PT-BR
  • Services
    • Manufacturing
      • Technology Transfer & Scale-Up
      • Commercial batches manufacturing
      • Small-batch manufacturing – rare diseases
      • Small-batch manufacturing – veterinary
    • Development
      • Formulation Development
      • Analytical Development
      • Clinical Batch & Placebo Manufacturing
      • Stability Studies
      • Ophthalmic Development
      • Co-Development Program
      • Regulatory Support
    • Out-licensing
      • Medical devices
      • Drugs
      • Product List
  • Solutions
    • By technology
      • Sterile liquids
      • Blow-Fill-Seal (BFS)
      • Multi-Dose
      • Non-sterile liquids
      • Stick-Pack
      • Spray
      • Bottle
      • Other
      • Solids & Semi-Solids
    • By therapeutic area
      • Ophthalmology
      • ENT
      • Injectable
      • Respiratory
      • Rare Diseases
      • Other Therapeutic Areas

    • Breakthrough Solutions
      • Euroject® – BFS Injectable
      • Carragelose – Viral Infection
      • Sol-Gel™ – Ophthalmology
      • Uniflash® – Oro-mucosal
    • Turnkey products
      • Medical devices
      • Drugs
      • Product List
  • The Group
    • About Us
      • About Us
      • Vision and Innovation
      • Executive Committee
      • History
    • Global presence
      • Overview
      • In France
      • In Brazil
      • In the United States
      • In China
    • Commitment
      • Cap 2030: our CSR strategy
      • Responsible Purchasing
    • News
      • News
      • Agenda
      • Press Area
  • Careers
    • Careers
      • Working at Unither
      • Our job opportunities
  • Inspire Hub
  • Contact
Site search
Press Enter to start the search
News
News

News

 Category filters

 Filter by categories:

 Select categories

 List of articles

Uncategorized

Laboratoire Kôl Olisens® eye drops, manufactured by Unither Pharmaceuticals

Blow-Fill-Seal: Sterile, Single-Use, Practical

Uncategorized

Innovation Insights with Éric Goupil and Nathalie Masson

Uncategorized

Unither shares its CSR Roadmap 2030 with customers

Uncategorized

Therapeutic and environmental benefits of the nebulized form in inhaled therapy for respiratory diseases

Uncategorized

Unither Satisfaction Survey – 2021

Uncategorized

Physiological serum, Rhinovirus and Sars-COV2

Liquid Delivery Systems for ENT Applications

Uncategorized

Why China is becoming strategic for Ophthalmology and CDMOs

Services

  • Manufacturing
  • Development
  • Out-licensing

Solutions

  • By technology
  • By therapeutic area
  • Breakthrough Solutions
  • Product notices

The group

  • About Us
  • Vision and Innovation
  • Executive Committee
  • History

Inspire Hub

Follow Us

  • X (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • YouTube (opens in a new tab)

Newsletter Signup

Newsletter
  • Legal links menu
  • Code of Conduct
  • Procurement Policy
  • Legal Notice
  • Privacy Policy
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.